"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."

During the past decade, Asklepios Fachklinikum Teupitz conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asklepios Fachklinikum Teupitz" #1 sponsor was "Hannover Medical School" with 2 trials, followed by "D-Pharm Ltd." with 1 trials sponsored, "Pierre Fabre Medicament" with 1 trials sponsored, "Sygnis Bioscience GmbH & Co KG" with 1 trials sponsored and "University Hospital, Essen" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Fachklinikum Teupitz" #1 collaborator was "Asklepios Fachklinikum Brandenburg" with 1 trials as a collaborator, "Asklepios Fachklinikum Lübben für Psychiatrie, Psychotherapie und Psychosomatik" with 1 trials as a collaborator, "Asklepios Fachklinikum Teupitz für Psychiatrie" with 1 trials as a collaborator, "Institut für Arzneimittelsicherheit in der Psychiatrie AMSP e.V." with 1 trials as a collaborator and "Kompetenznetz TDM KJP e.V." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Asklepios Fachklinikum Teupitz" are "Acute Ischemic Stroke" (2 trials), "Anxiety Disorders" (2 trials), "Dementia" (2 trials), "Depression" (2 trials) and "Psychosomatic Disorders" (2 trials). Many other conditions were trialed in "Asklepios Fachklinikum Teupitz" in a lesser frequency.

Most popular intervention types in "Asklepios Fachklinikum Teupitz" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acamprosate" (1 trials), "Agomelatine" (1 trials), "Alprazolam" (1 trials), "Amisulpride" (1 trials) and "Amitriptyline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios Fachklinikum Teupitz" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Asklepios Fachklinikum Teupitz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Asklepios Fachklinikum Teupitz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios Fachklinikum Teupitz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".